News

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Eli Lilly ( LLY 2.92%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...
Medically reviewed by Kelly Wood, MD Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...